PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2020-02-13

Date Title Company
13-Feb-2020 miR Scientific Presents Breakthrough New Data on the miR Scientific Sentinel(TM) Tests for the Detection and Classification of Prostate Cancer at the 2020 ASCO Genitourinary Cancers Symposium (February 13-15 in San Francisco, Calif.) miR Scientific
13-Feb-2020 miR Scientific Presents Breakthrough New Data on the miR Scientific Sentinel(TM) Tests for the Detection and Classification of Prostate Cancer at the 2020 ASCO Genitourinary Cancers Symposium (February 13-15 in San Francisco, Calif.) miR Scientific
13-Feb-2020 Phio Pharmaceuticals Announces Closing of $8.0 Million Underwritten Public Offering Phio Pharmaceuticals Corp.
13-Feb-2020 Phio Pharmaceuticals Announces Closing of $8.0 Million Underwritten Public Offering Phio Pharmaceuticals Corp.
13-Feb-2020 VistaGen Therapeutics Reports Fiscal 2020 Third Quarter Financial Results and Provides CNS Pipeline Overview VistaGen Therapeutics
13-Feb-2020 Regulus Therapeutics Reinitiates Multiple Ascending Dose Study of RGLS4326 for the Treatment of ADPKD Regulus Therapeutics Inc.
13-Feb-2020 Release of results for the first quarter 2019/20 (ending 31 December 2019) on 19 February 2020 Douglas GmbH
13-Feb-2020 Launch of innovative medical food provides a palatable new option for people diagnosed with rare metabolic disorder in the UK Galen
13-Feb-2020 BioNTech Announces Commencement of Public Offering of American Depositary Shares BioNTech
13-Feb-2020 RauCon Pharma Partnering Conferences Limit Attendance For More Value RauCon GmbH & Co
13-Feb-2020 Takeda Demonstrates Ongoing Commitment in Rare Hematology By Continuing to Gather Real-World Evidence and Advance Personalized Treatment Takeda Pharmaceutical Company
13-Feb-2020 Innovative – Compliant – Trusted: Copley marks a new decade with a major rebrand and a new product range. Copley Scientifi
13-Feb-2020 ‘Genetic rewiring’ drives cancer’s drug resistance The Institute of Cancer Research
13-Feb-2020 Abeona Therapeutics Announces Positive Interim Data from MPS III Gene Therapy Programs Presented at WORLDSymposium™ Abeona Therapeutics Inc.
13-Feb-2020 Sosei Heptares Operational HighlightsSosei Heptares Operational Highlights and Consolidated Results for the 12 Months ended 31 December 2019 and Consolidated Results for the 12 Months ended 31 December 2019 Sosei Heptares
13-Feb-2020 First patient dosed in pivotal phase 3 trial of SNF472 in calciphylaxis Sanifit
13-Feb-2020 The Alliance for Regenerative Medicine Releases Agenda for 2020 Cell & Gene Meeting on the Mediterranean Alliance for Regenerative Medicine
13-Feb-2020 Futura provides update on positive EU regulatory discussions and further ongoing analysis of FM57 Futura Medical plc
13-Feb-2020 New gene mutation associated with Fabry cardiomyopathy University of Eastern Finland
13-Feb-2020 SCTM roadmap and committed funding will boost Australia’s position in Asia-Pacific stem cell research landscape, says GlobalData GlobalData